Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoblast responses to nucleotides increase during differentiation.

Isabel R Orriss1, Gillian E Knight, Sam Ranasinghe

  • 1Department of Anatomy and Developmental Biology, University College London, London WC1E 6BT, UK.

Bone
|April 18, 2006
PubMed
Summary

Extracellular nucleotides, signaling via P2 receptors, influence bone cell function. Mature osteoblasts show increased responsiveness, with P2Y(2) receptors potentially acting as

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation and characterization of an immortalized equine osteoblast cell line.

Veterinary journal (London, England : 1997)·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025
Same author

Author Correction: Hypoxia mimetics restore bone biomineralisation in hyperglycaemic environments.

Scientific reports·2025
Same author

Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies.

Bone research·2025
Same author

Extracellular pH is a critical regulator of osteoclast fusion, size and activation.

Bone·2025
Same author

The microRNA-455 null mouse shows dysregulated bone turnover.

JBMR plus·2025

Area of Science:

  • Bone Biology
  • Cell Signaling
  • Receptor Pharmacology

Background:

  • Extracellular nucleotides and P2 receptors are implicated in bone cell function.
  • ATP and ADP stimulate osteoclastic resorption, while ATP and UTP inhibit osteoblast bone formation.
  • Understanding P2 receptor expression during osteoblast differentiation is crucial for bone metabolism research.

Purpose of the Study:

  • To investigate changes in P2 receptor expression and function during primary osteoblast differentiation.
  • To determine the role of specific P2 receptors in modulating osteoblast activity and bone formation.
  • To identify potential therapeutic targets for bone diseases based on nucleotide signaling.

Main Methods:

  • Primary rat calvarial osteoblasts were cultured and differentiated for up to 10 days.

Related Experiment Videos

  • Intracellular calcium responses to nucleotide agonists were measured using fluorescence imaging.
  • Messenger RNA (mRNA) expression, Western blotting, and immunostaining were employed to analyze P2 receptor expression.
  • The effect of nucleotide exposure on bone nodule formation was assessed.

    • Main Results:

    • Osteoblast responsiveness to ATP and UTP increased significantly with differentiation, correlating with increased intracellular calcium.
    • The expression profile of P2 receptors shifted during differentiation, with a notable increase in P2Y(2) receptor mRNA in mature osteoblasts.
    • Mature osteoblasts preferentially expressed P2Y(2), P2Y(4), and P2Y(6) receptors, while P2X receptor expression generally decreased.
    • Exposure to ATP or UTP inhibited the formation of mineralized bone nodules, whereas UDP and ADP had no effect.

    Conclusions:

    • Osteoblast differentiation is accompanied by a shift in P2 receptor expression, favoring P2Y receptors, particularly P2Y(2).
    • The P2Y(2) receptor, and potentially P2Y(4), may act as negative regulators or 'off-switches' for mineralized bone formation.
    • These findings highlight the critical role of nucleotide signaling in regulating bone formation and suggest P2 receptors as potential targets for therapeutic intervention in bone disorders.